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Summary A retrospective histopathological review of 2104 cases of solid tumour was carried out to assess the variability in diagnosis of
childhood cancer. Cases were subject to three independent, concurrent opinions from a national panel of specialist pathologists. The
conformity between them was analysed using the percentage of agreement and the kappa statistic (ic), a measure of the level of agreement
beyond that which could occur by chance alone, and weighted kappa (wic), which demonstrates the degree of variation between opinions.
The major groupings of the Birch-Marsden classification were used within which tumours were assigned for kappa analysis according to the
clinical significance of the differential diagnoses. The mean agreement for all tumours together was 90%; 1C=0.82, wKi=0.82. Retinoblastoma
achieved the highest kappa value (1.0) and lymphoma the lowest (0.66). Of the cases, 16.5% had their original diagnoses amended and the
panel confirmed the original diagnosis of paediatric pathologists in 89% of cases compared with 78% for general pathologists. The varying
levels of agreement between experts confirm the difficulty of diagnosis in some tumour types, suggesting justification for specialist review in
most diagnoses. Specialist training in paediatric pathology is also recommended.
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Cancer in children is rare, accounting for only 0.5% of all malig-
nancies in all age groups (Stiller, 1992) in developed societies.
Treatment is now sophisticated and more specifically targeted at
different types and subtypes ofdisease than in earlier years, but, as
it can also have long-term consequences, it is essential that unnec-
essary effects are avoided by ensuring that the therapy is appro-
priate to the disease; this demands accurate diagnosis from the
outset. The development of new stains and techniques has
enhanced diagnostic precision over the years, but there remain
cases that are difficult to classify.
The West Midlands Regional Children's Tumour Research
Group (WMRCTRG) is a specialist regional registry, holding data
on all childhood cancers diagnosed in the West Midlands Health
Authority Region (WMHAR) since 1957 (Muir et al, 1992).
Histopathological review has been a major element ofthe Group's
work and a large archive collection of slides has been built up.
This report describes the analysis of the level of agreement
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between the reviewers to assess the scale ofany variation. We also
compared the original diagnoses with those arrived atby thepanel.
We recognize that in this analysis we are not comparing 'like with
like' in that the current reviewers will have had access to stains
and techniques that were not available to the original pathologists.
However, we chose to undertake this investigation to gain some
indication ofwhether there have been changes in the classification
ofchildhood tumours.
MATERIALS AND METHODS
Cases reviewed comprised all solid tumours diagnosed between
1957-92; leukaemia cases were excluded, because of the poor
preservation ofbone marrow specimens overtime. The review was
co-ordinated by Dr A Hugh Cameron (AHC), Consultant
Histopathologist at the Children's Hospital, Birmingham (BCH)
from 1957-84. Each case was subject to three independent, concur-
rent opinions i.e., those of AHC and two further pathologists; the
13 referees were recruited on the basis oftheir professional experi-
ence and specialist interest in particular tumour groups.
The review diagnoses were based on at least three sections of
the material, one stained with haematoxylin and eosin, this being
the major routine diagnostic method (Triche, 1992), and the other
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Table 1 Soft tissue sarcomas: inter-reviewer agreement
Referee 1
Referee 2 RMSa Other STS Other malignant Benign tumours No tumour Total
RMS 127 1 - 1 - 129
Other STS 4 38 4 3 - 49
Other malignant 4 3 7 - - 14
Benign 1 5 - 40 1 47
No tumour - - - 3 1 4
Total 136 47 11 47 2 243
aRMS rhabdomyosarcoma. Percentage of agreement, 88%; kappa statistic, 0.80; weighted kappa, 0.89.
Table 2 Summary of inter-reviewer analyses, soft tissue sarcoma
Percentage Kappa Weighted No. of cases
agreement kappa reviewed
Ref 1 vs Ref 2 88 0.80 0.89 243
Ref 1 vs Ref 3 79 0.70 0.85 96
Ref 2 vsRef 3 77 0.67 0.85 91
Overall mean 81 0.72 0.86
Ref, referee.
Table 3 All tumours: inter-reviewer consensus
Tumour type Mean percentage Mean Mean weighted
agreement kappa kappa
Retinoblastoma 100 1.00 1.00
Renal tumours 98 0.88 0.83
Sympathetic chain 95 0.75 0.91
Bone tumours 94 0.89 0.79
Germ cell tumours 93 0.87 0.77
Hepatic tumours 90 0.83 0.71
Epithelial tumours 89 0.85 0.63
CNSa tumours 85 0.81 0.93
Soft tissue sarcoma 81 0.72 0.86
Lymphoma 78 0.66 0.75
Overall mean 90 0.82 0.82
aCNS tumours, brain and central nervous system.
two unstained to enable special stains as chosen by the referee if
required. No other diagnostic aids were supplied, the pathologists
being obliged to treat it as a 'blind' exercise. The review opinions
were stored on a computer database and collated when the exercise
was completed. When at least two ofthe three opinions coincided,
this was accepted as agreement and confirmed as the final review
diagnosis ('consensus').
The Birch-Marsden classification of childhood tumours (Birch
and Marsden, 1987) was used, which subdivides the cases into ten
major solid tumour groups. Within these, the categories chosen for
comparison in the statistical analysis were assigned by three
consultant paediatric oncologists (JRM, BJM, MCGS). Distinction
was first made between malignant orbenign tumour; then opinions
were grouped broadly on the basis of differential diagnoses that
would involve major treatment variations. Thus, a difference in
classification does not merely represent an academic histopatho-
logical difference but could have implications for clinical care.
Table 4 Cases diagnosed as malignant, deleted after review (23)a
B-M classification Original diagnosis Final diagnosis
of original diagnosis
2a Hodgkin's disease Lymphadenitis
2b NHL Post-viral syndrome
Anaplastic lymphoma Inflammation
Malignant NHL Reactive tissue
Immunoblastic lymphoma Viral reaction
Reticulum cell sarcoma Hyperplasia
2e Histiocytosis X Reactive tissue
4a Neuroblastoma Hamartoma
Neuroblastoma Malformation
6a Wilms' tumour Cystic kidneys
7a Malignant liver tumour Cirrhosis
9a Rhabdomyosarcoma Benign polyp
lid Malignant melanoma Benign melanoma
Malignant melanoma (6) Naevus
In situ melanoma Naevus
Basal cell carcinoma Naevus
Squamous carcinoma Hyperplasia
lie Intraductal carcinoma Hyperplasia
aOne case of each, except where specified. Birch - Marsden classification.
Variability of opinion, even between experts, can be summa-
rized statistically in two ways, the first being a simple measure of
unanimity (i.e. the proportion in which there was agreement).
However, as this does not take account ofthe role ofchance (i.e. a
'best guess' diagnosis in the event of doubt) or subjectivity in the
process, a statistical assessment is desirable. In order to evaluate
the consistency between the reviewers, we used the kappa (K)
statistic (Cohen, 1960, 1968; Maxwell, 1977; Altman, 1990),
which is based on a nominal scale of categories for analysis and
assesses the agreement between independent observers beyond
that which would occur by chance (a value of 1.0 indicates perfect
agreement). As interpretation of the kappa statistic is subjective,
requiring ad hoc assignment (Bland and Altman 1986; Maclure &
Willett 1987, Altman, 1990), we chose the following scale: <0.50,
0.5-0.74, 0.75-0.89 and >0.89, representing poor, fair, good and
very good agreement respectively.
Weighted kappa (wic) analysis (Cohen, 1968; Altman, 1990)
was also included to assess the degree of variation when the opin-
ions differed. This process creates an ordinal scale by assigning
graded 'weights' (or penalties) to each category outside the diag-
onal line that links the agreed cases, according to the number of
categories by which it differs. Again, a value of 1.0 denotes no
variation between opinions. In this setting, wic demonstrates the
clinical significance ofthe disagreements.
British Journal ofCancer (1997) 75(8), 1156-1159 0 Cancer Research Campaign 19971158 SE Parkes etal
Table 5 All tumours: original vs panel diagnoses
Tumour type Mean percentage Mean kappa Mean weighted
agreement kappa
Retinoblastoma 100 1.00 1.00
Renal tumours 96 0.68 0.69
Germ cell tumours 93 0.86 0.77
Sympathetic chain 92 0.62 0.71
Bone tumours 91 0.84 0.74
Epithelial tumours 87 0.82 0.59
CNS tumours 86 0.80 0.81
Soft tissue sarcomas 72 0.60 0.75
Lymphomas 68 0.54 0.71
Hepatic tumours 65 0.37 0.50
Overall mean 85 0.71 0.73
Table 6 All tumours: original vs panel by place of diagnosis
Tumour type BCH cases Non-BCH cases
(mean) (mean)
% K WK % K WK
Retinoblastoma 100 1.00 1.00 100 1.00 1.00
Bone tumours 100 1.00 1.00 89 0.80 0.73
Germ cell tumours 97 0.91 0.79 96 0.91 0.77
Sympathetic chain 97 0.83 0.87 74 0.29 0.30
Renal tumours 95 0.67 0.65 97 0.49 0.28
CNS 85 0.80 0.78 82 0.76 0.85
Soft tissue sarcoma 85 0.77 0.91 56 0.42 0.47
Hepatic tumours 78 0.58 0.64 46 0.15 0.20
Lymphoma 76 0.64 0.82 63 0.49 0.57
Epithelial tumours 73 0.62 0.39 80 0.73 0.44
Overall mean 89 0.76 0.78 78 0.59 0.54
RESULTS
The pathology review began in November 1984 and included
cases diagnosed up to the end of 1992. Of the 4592 eligible, 1472
(32%) were leukaemias and were not reviewed. Of the 1116 (24%)
brain and CNS tumours, pathology material was reviewed in 482.
Of the other 2004 (44%) cases, 382 were not reviewed either
because there had not been a biopsy/excision or because the
pathology material was no longer available. Thus, 2104 cases
underwent review.
The results of the analyses are summarized below, with one
category, soft tissue sarcoma (STS), described in detail. Table 1
displays the opinions of two reviewers in the grid formed from the
five main categories, the horizontal showing those of the first
referee, the vertical those of the second and the diagonal line
reveals those cases in which there was agreement (213/243, 88%).
The kappa statistic (0.80) shows good agreement between these
two reviewers beyond that which could occur randomly and wK
(0.89) implies that when disagreement did occur, the clinical
significance of the variation was not major. Table 2 illustrates the
results of the review for the whole STS group, in which the large
number ofdisagreements resulted in only fair agreement (K=0.72),
although the high wK (0.86) suggests that, overall, these disagree-
ments were again not major in terms of clinical significance.
Table 3 summarizes the results for the whole series of tumours
using the means of the three separate analyses and shows varia-
tions in agreement from 100% in retinoblastoma to 78% in
lymphoma. The overall level of agreement was very good (90%),
with high K (0.82) and WK (0.82) values. Ofthe ten tumour group-
ings, only soft tissue sarcoma and lymphoma showed 'fair' agree-
ment (K<0.75). The effect of wK on the analyses is seen in CNS
tumours which did not have the highest percentage of agreement
(85%) but had the highest wK (0.93) showing that, in the 15% of
cases in which disagreements did occur, these were ofminor clin-
ical significance. This result could also reflect the number of cate-
gories in the analysis, which in tum is influenced by the treatment
available for these tumours.
We found that 348 (16.5%) ofthe 2104 original diagnoses were
amended in some way by the review panel. In addition, in 23 cases
that had been diagnosed as malignant, the final consensus was that
they were not neoplasms, and they were deleted from the Register
(Table 4). Table 5 illustrates the results ofthe comparison between
the original and the review diagnoses, in which the difference
between the basic percentage ofagreement and the kappa values is
quite marked. For example, in renal tumours, there was very good
agreement (92%) with the original diagnosis, but therelatively low
K (0.68) indicates that the agreement beyond chance was only
moderate.
In order to identify any indication of differences between those
cases originally diagnosed by paediatric and general pathologists,
Table 6 compares the cases originating from BCH (diagnosed by a
paediatric pathologist) with those from other hospif'als (general
pathologists). The panel agreed with the former diagnoses more
often than with the latter (K=0.76 and 0.59 respectively). Only in
epithelial tumours (carcinoma) was there better agreement with the
panel for those diagnosed outside the paediatric centre (80% vs
73%, Ki=0.73 vs 0.62).
DISCUSSION
Expert pathology review has been shown to be important in the
diagnosis of cancer at any age (Presant et al, 1986; Segelov et al,
1993). For example, Segelov et al (1993), in their review of adult
testicular tumours, found that in 28 out of 87 (32%) patients, the
diagnosis made on referral to the specialist centre differed from the
original. As paediatric tumours are less common and treatment
effects potentially more damaging, specialist diagnostic expertise
in referral centres is vital. It has been suggested that the results of
variation studies of the pathology diagnostic process could and
should have an effect on practice (Machin and Parmar, 1994).
The present large study is the firstofits kind in paediatric disease,
covering the whole spectrum of childhood solid tumours. In addi-
tion tocomparing initial and final diagnoses, as has often been done
in pathology review reports from clinical trials, we have assessed
the level ofdisagreement between reviewers. Freedman and Machin
(1993) identified two main issues in the design of observer agree-
ment studies in pathology review, the first being the number and
selection ofreferees. Ours were selected on the basis oftheirprofes-
sional experience and specialist interest in specific tumour types,
and each case was subject to three opinions, this being deemed
appropriate to allow a consensus to be reached. A second require-
ment is replicate assessment of slides to quantify how much of the
observed non-uniformity is due to intra-rather than inter-observer
variability, but this aspect was not assessed in the current study.
However, as AHC was both original pathologist for many of the
BCH cases and also a member ofthe panel, we assessed changes in
his opinion, as a way of testing for intra-observer differences and
found that his diagnosis differed in only 8% ofcases (57/664).
British Journal of Cancer(1997) 75(8), 1156-1159 0CancerResearch Campaign 1997Pathologyin paediatriccancer 1159
The 90% overall level of agreement is good. Kappa and
weighted Kappa (0.82 and 0.82 respectively) illustrate further the
levels of agreement beyond chance and of variation between
reviewers and show that, for most categories, these were also
good. This 'league table' ofresults could be seen as a guideline as
to which tumour types might benefit from second opinion before
treatment is instituted. It is increasingly common practice for
collaborative clinical trials in paediatric oncology to demand
specialist review, and our results confirm thejustification for this
as part of good clinical practice as even small levels of disagree-
ment could have clinical significance forthe patient. The degree of
inter-observer variability reported underlines the inherent subjec-
tivity and possible limitations ofa single diagnosing pathologist in
difficult cases. Consistency in terminology and nomenclature is
essential and could best be achieved through uniformity of
specialist training in paediatric pathology.
The comparison between initial and review diagnoses is limited
in retrospective reports by the consideration of advances in knowl-
edge. We have therefore attempted to allow for changes in nomen-
clature, by grouping 'new' diagnoses under their previous
classifications (e.g. primitive neuroectodermal tumour (PNET) with
medulloblastoma, etc.). Table 5 shows that, inthiscomparison, there
was less good overall agreement than was seen within the review
panel (85% compared with 90%). This illustrates that paediatric
pathology has advanced and that tumours can now be more reliably
identified (although we are unable to specify further the roles in this
study of specialist stains or other factors). Technical advances are
continuing to be made, thus constantly improving diagnostic preci-
sion, and newer techniques, such as molecular genetics (which is
currently more of a research tool), will become indispensable. The
analysis by originating hospital shows that paediatric pathologists
were more likely to arrive at the panel's definitive diagnosis than
were general pathologists. An exception was. noted for carcinomas
which are generally regarded as 'adult' cancers and which appeared
to be more successfully diagnosed by the adult (80% agreement)
than the paediatric (73%)pathologists; this presumably reflects their
greater familiarity with this form ofthe disease.
This study shows good overall agreement in the majority of
tumour types, although it also demonstrates that, even among
experts, identification ofclinically significant groupings, based on
histopathological examination alone, was not unanimous. This
conclusion must be placed in the context that the final diagnosis in
the clinical setting does not depend on pathology material alone
but is supplemented by other diagnostic information. Our results
do not imply, therefore, that any patients will necessarily have
been misdiagnosed, and no judgment is implied in the results of
this review either of inaccuracy or of infallibility. We do not
suggest that there is an association between a change ofdiagnosis
as a result ofthis review and the appropriateness oforiginal treat-
ment or ultimate outcome. We would simply say that our results
support the case for routine review in most childhood tumours to
improve the reliability ofthis component ofthe diagnostic process.
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